Theravance Biopharma Inc (TBPH) — Financial Flexibility Index
Theravance Biopharma Inc (TBPH) has a Financial Flexibility Index of -0.03x as of December 2025. Free cash flow of $-6.06 Million (operating CF $-6.06 Million minus capex $8.00K) represents 0% of total liabilities ($188.85 Million). Check Theravance Biopharma Inc (TBPH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Theravance Biopharma Inc Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Theravance Biopharma Inc across 15 annual periods. For the full cash flow conversion analysis, see Theravance Biopharma Inc cash conversion from operations.
Annual Financial Flexibility Index for Theravance Biopharma Inc (2011–2025)
Year-by-year free cash flow to debt coverage for Theravance Biopharma Inc. Explore Theravance Biopharma Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.26x | $238.58 Million | $238.54 Million | $188.85 Million | ▲ +2114.3% |
| 2024 | -0.06x | $-11.20 Million | $-11.54 Million | $178.62 Million | ▲ +56.8% |
| 2023 | -0.15x | $-24.51 Million | $-27.00 Million | $169.00 Million | ▲ +87.1% |
| 2022 | -1.13x | $-186.42 Million | $-186.99 Million | $165.60 Million | ▼ -292.8% |
| 2021 | -0.29x | $-204.45 Million | $-207.86 Million | $713.39 Million | ▲ +9.2% |
| 2020 | -0.32x | $-243.79 Million | $-250.40 Million | $772.81 Million | ▲ +15.1% |
| 2019 | -0.37x | $-235.02 Million | $-238.20 Million | $632.67 Million | ▼ -115.2% |
| 2018 | -0.17x | $-105.63 Million | $-112.87 Million | $611.82 Million | ▲ +71.6% |
| 2017 | -0.61x | $-198.65 Million | $-201.05 Million | $326.22 Million | ▼ -81.7% |
| 2016 | -0.34x | $-96.85 Million | $-98.99 Million | $289.02 Million | ▲ +88.5% |
| 2015 | -2.91x | $-166.21 Million | $-168.86 Million | $57.05 Million | ▲ +18.7% |
| 2014 | -3.59x | $-172.05 Million | $-175.16 Million | $47.98 Million | ▼ -28.0% |
| 2013 | -2.80x | $-118.22 Million | $-120.96 Million | $42.21 Million | ▲ +45.5% |
| 2012 | -5.14x | $-116.52 Million | $-119.11 Million | $22.67 Million | ▼ -895.3% |
| 2011 | -0.52x | $-79.80 Million | $-83.43 Million | $154.54 Million | — |